Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Johnson and Johnson
McKesson
Harvard Business School
Argus Health
Accenture
Dow
Chinese Patent Office
Novartis

Generated: February 19, 2018

DrugPatentWatch Database Preview

Merro Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for MERRO PHARM, and what generic and branded alternatives to MERRO PHARM drugs are available?

MERRO PHARM has one approved drug.



Summary for Merro Pharm
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Merro Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merro Pharm IBUPROFEN ibuprofen TABLET;ORAL 070985-001 Oct 2, 1987 OTC No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Accenture
Medtronic
Moodys
Baxter
Express Scripts
McKesson
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot